“Methods: In this case–control clinical study, a total number of 70 patients with T2DM compared with 30 healthy controls were divided into …: Group A (n = 30), healthy controls; Group B (n = 36), T2DM patients on metformin and Group C (n = 34), T2DM patients on metformin … TA 600 …/day.”
“sVCAM-1 level was high in patients with T2DM (3.74 ± 1.34 …, which decreased by metformin monotherapy to 2.32 ± 0.67 ng/ml or metformin … TA to 1.98 ± 0.31 ng/ml (P < 0.01), but … illustrated insignificant difference compared to metformin alone (P = 0.29).”